Invenomic Capital Management’s Best Buy BBY Stock Holding History

Invenomic Capital Management’s Portfolio BBY Stock Details BBY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-32,215	Closed	-$2.72M	–	145
2024 Q2	$2.72M	Buy	+32,215	New	+$2.56M	0.13%	134

Other funds holding BBY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invenomic Capital Management's BBY Position: Q3 2024 in Review

Invenomic Capital Management sold out of Best Buy (BBY) in Q3 2024, closing a stake of 32,215 shares — an estimated $2.72M sold.

Invenomic Capital Management first reported a position in BBY in Q2 2024 and held it in 1 quarter. The position peaked at $2.72M in Q2 2024. 873 funds tracked by Wall St. Rank hold BBY as of Q3 2024.

Invenomic Capital Management reported no remaining Best Buy position as of Q3 2024 after selling out during the quarter.
Invenomic Capital Management sold 32,215 Best Buy shares in Q3 2024, an estimated $2.72M.
Invenomic Capital Management first reported a position in Best Buy in Q2 2024 and held it in 1 quarter.
Invenomic Capital Management's Best Buy position peaked at $2.72M in Q2 2024.
873 funds tracked by Wall St. Rank held Best Buy as of Q3 2024.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.